<PAGE>
EXHIBIT 23.2
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected Financial
Data" and "Experts" and to the use of our report dated July 21, 2000 (except
Note 12, as to which the date is October 13, 2000) in the Post-Effective
Amendment No. 4 to the Registration Statement on Form SB-2 and related
Prospectus of Cortex Pharmaceuticals, Inc. for the registration of shares of its
common stock.
/s/ Ernst & Young LLP
ERNST & YOUNG LLP
San Diego, California
October 27, 2000
